Abstract: The invention relates to a compound which inhibits the importation of chloride into neurons or a compound which improve the outflow of chloride from neurons for use in the treatment of autism in a baby or a fetus in need thereof.
Type:
Grant
Filed:
November 22, 2013
Date of Patent:
March 14, 2017
Assignees:
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE D'AIX MARSEILLE, CHU DE BREST
Inventors:
Yehezkel Ben-Ari, Diana Carolina Ferrari, Romain Nardou, Eric LeMonnier
Abstract: A compound which inhibits the importation of chloride into neurons and a compound which improve the outflow of chloride from neurons for the use in treatment of autism, a pharmaceutical composition for use in the treatment of autism including such compound and a pharmaceutically acceptable carrier are described.
Type:
Grant
Filed:
January 13, 2011
Date of Patent:
August 16, 2016
Assignees:
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE D'AIX MARSEILLE, CHU DE BREST
Abstract: A compound which inhibits the importation of chloride into neurons and a compound which improve the outflow of chloride from neurons for the use in treatment of autism, a pharmaceutical composition for use in the treatment of autism including such compound and a pharmaceutically acceptable carrier are described.
Type:
Application
Filed:
January 13, 2011
Publication date:
January 24, 2013
Applicants:
CHU DE BREST, UNIVERSITE D'AIX MARSEILLE